Why do women live longer but not healthier?
Women outlive men in nearly every country on earth. The global gap is about 5 years. In Germany it is 4.6 years: 83.4 for women versus 78.8 for men, according to the latest Destatis life tables (2023/25) [14]. But women spend more of those bonus years in poor health. So the real puzzle of women's longevity is not living longer. It is the gap between how long you live and how long you stay well.
A few biological differences set the whole thing up.
Two X chromosomes are a backup copy: Think of your genes as a set of instructions. Women carry two X chromosomes, so if one has a typo, the other copy covers for it. Men only have one X, so there is no backup. That is part of why women tend to have stronger immune systems and fewer of certain genetic conditions.
Estrogen is quietly doing a lot of work: Before menopause, estrogen looks after your heart and metabolism in the background. It keeps cholesterol in a good range, keeps blood vessels flexible, keeps bones dense, and keeps inflammation low. When estrogen drops at menopause, that protection drops with it. It is a real turning point, not a slow fade.
The strong immune system has a downside: Women account for roughly 80% of autoimmune disease cases. That is when your immune system attacks your own body. Rheumatoid arthritis, lupus, Hashimoto's thyroiditis. They all hit women much harder and chip away at healthy years.
The healthspan gap is real: Women live longer, but WHO and EU data keep showing the same thing. Women report more years with disability and chronic disease. Closing that gap takes a plan built around how women actually age. Generic longevity advice misses it.
Most of the research was done on men (and that is a real problem): A lot of the longevity studies people quote skewed heavily male in their early phases. Early rapamycin pilots, senolytics and GLP-1 longevity sub-studies all fit that pattern. Two cases cut the other way. The metformin TAME trial was designed for roughly 50/50 enrolment, though as of 2026 its recruitment is still pending under the originally planned protocol. And CALERIE Phase 2, the big calorie-restriction trial, was about 70% female [6]. Almost none of these studies report results split out by sex. Several reviews have flagged this gap. So when you see a longevity protocol that was tested mostly on men, treat it as a starting sketch that needs adjusting for female bodies. Blueprint, the classic calorie-restriction protocols, Attia's training plans, Huberman's cold and light routines. All of them were dialed in on male physiology first.
Which hormones change in menopause?
Hormones are the single biggest driver of how women age. Once you know the timeline and what each phase does to your body, you can get ahead of it instead of getting blindsided. Our dedicated guides go deeper on perimenopause and on hormone replacement therapy.
The hormonal timeline:
- Perimenopause (typically ages 40 to 51): Estrogen and progesterone start swinging around with no warning. Periods get irregular. Sleep breaks. Mood shifts. Hot flashes show up. This phase can run 4 to 10 years.
- Menopause (average age 51): You can only name it looking back: after 12 months in a row with no period. Estradiol, your main active estrogen, drops by roughly 90% from its peak. After that, a weaker estrogen called estrone takes over as the main one still circulating.
- Post-menopause: The decades that follow, when low estrogen speeds up bone loss, pushes up heart risk, and shifts your metabolism.
Not sure which phase you are in? Our menopause test sorts your symptoms.
Hormone replacement therapy (HRT): The science on HRT has flipped around a lot, so it is worth understanding. The first big Women's Health Initiative (WHI) study back in 2002 raised alarms about breast cancer and heart risk [7]. Then researchers reanalyzed the data and ran newer studies, and the picture got more nuanced. Here is where it stands:
- When the WHI team split the results by age, women who were 50 to 59 at the start showed a more favorable survival trend than women aged 70 to 79. It was clearest during the years they actually took the hormones. Splitting by years since menopause looked similar, with less statistical power. The trial as a whole came out neutral, meaning no overall difference in deaths from any cause (HR 0.99, basically a tie) [1]. This is the "timing hypothesis": start early and the math looks better. Major menopause guidelines (NAMS and IMS) still back it. The one trial built to test it, ELITE, found estradiol slowed artery-wall thickening only in women who started within 6 years of menopause, not in women 10 or more years out [8]. That is an ultrasound marker, not heart attacks or deaths, so proof on hard outcomes is still missing.
- How you take it matters more than whether the label says "bioidentical." Two big reviews, the IMS 2024 White Paper [9] and the NAMS 2022 position paper [5], point the same way. Estradiol absorbed through the skin (a patch or gel) looks easier on blood-clot and stroke risk than the old estrogen pills made from horse urine. That evidence is observational, mainly from two French studies, the E3N cohort and ESTHER. Micronized progesterone (the body-identical kind) also looks gentler on breast tissue than older synthetic progestins like MPA (medroxyprogesterone acetate, the one used in WHI). Nobody has run head-to-head trials comparing progesterone types on breast-cancer outcomes yet, so this is the best read of observational data, not proof. Prescribing is still individual.
- When HRT is off the table entirely: current breast or other hormone-sensitive cancer, a past blood clot that came out of nowhere or an active one, active heart or stroke disease, unexplained vaginal bleeding, severe liver disease, or a known clotting disorder. This is exactly why you go through it with a doctor who actually does menopause care.
- The upside for bones, hot flashes, and quality of life is well established.
- What changed in 2025: In November 2025 the US FDA announced it is removing the boxed warnings on menopause hormone therapy about heart disease, breast cancer and probable dementia. The labels will advise starting systemic HRT within 10 years of menopause or before 60. The warning about cancer of the uterine lining stays for estrogen taken without a progestogen [10].
The thyroid connection: Women are 5 to 8 times more likely than men to run into thyroid problems. An underactive thyroid (called hypothyroidism, when the gland makes too little hormone) is common as women age and can look exactly like menopause, or make it worse. It can speed up aging too. So get your thyroid checked regularly (the TSH and free T4 blood tests), especially after 35.
Estrogen is not the whole story: DHEA and testosterone also drop with age in women. Yes, women have testosterone too. When it runs low you see less muscle, lower sex drive, and less energy. These hormones are getting more attention in full-picture care.
Cycle-specific markers: In perimenopause, the classic hormone levels are unreliable because they swing hard across the cycle. FSH (the hormone that tells your ovaries to ripen an egg), measured on day 3 of your cycle, tells you little once your cycles get irregular. AMH (anti-Müllerian hormone) gives a steadier estimate of your ovarian reserve, roughly how many eggs you have left. Estradiol and progesterone measured in the luteal phase (the second half of your cycle, after ovulation) hint at whether you are still ovulating. Read your symptom diary and the markers together, not in isolation.
How do women protect bone and muscle?
Losing bone and muscle is one of the most serious parts of aging for women, and the numbers are blunt. 1 in 3 women over 50 will break a bone because of osteoporosis (when bones get thin and brittle). For men it is 1 in 5. And a broken hip is not a minor thing. In older adults, roughly 20 to 25% die within a year of a hip fracture.
Why women are more exposed:
- Women start adult life with less bone to begin with than men.
- When estrogen drops at menopause, bone loss speeds up fast. A long-running study called SWAN tracked exactly this across the menopause [2]. In the roughly 3-year window around the final period, women lost about 7.4% of bone in the lower spine and 5.8% at the hip (around 2.5% and 1.8% per year). Stretch it to 10 years and it adds up to roughly 10.6% in the spine and 9.1% at the hip. The pace was not the same for everyone. Some analyses in SWAN found faster yearly loss in Asian women (Chinese and Japanese) than in white or African American women, and how much you lose in total depends on how much bone you had to start with. Severe cases can run higher.
- Women also live longer, so the loss has more years to pile up.
Lifting weights is not optional: Strength training is the single most effective thing a woman can do for her bones and muscle. It:
- Tells bones to get stronger by physically loading them
- Builds and holds onto muscle, which fights sarcopenia (the muscle loss that comes with age)
- Improves balance and cuts your risk of falling
- Helps your metabolism and how well your body handles blood sugar
Women who lift 2 to 3 times a week can hold their bone density or even build it back. Skip it, and you lose it bit by bit.
Calcium and vitamin D: The classic bone pair. Over 50, aim for about 1,000 to 1,200 mg of calcium a day, ideally from food, plus 1000 to 2000 IU of vitamin D3. Some doctors also add vitamin K2, the idea being it helps steer calcium into bone rather than arteries. The hard outcome evidence is mixed, though. Europe's food-safety authority (EFSA) actually rejected the K2-specific heart-and-blood-vessel claims in 2012 and again in 2020 [19, 20]. The only vitamin K claims the EU does allow (under Reg 432/2012) are the generic ones: that vitamin K helps normal blood clotting and helps keep bones normal. So treat K2 as optional, not a must.
Sarcopenia, the quiet one: Muscle loss starts around age 30 and picks up speed after menopause. Women can lose 3 to 8% of muscle per decade after 30, and the rate climbs once menopause hits. The fix is straightforward: eat enough protein (at least 1.2 g per kg of body weight) and lift weights.
Bone protection, in practice:
- Know when to get a DEXA scan (the standard bone-density X-ray). The US screening panel USPSTF updated its advice on 14 January 2025.
- At 65 or older: get one routinely (Grade B, meaning USPSTF recommends it).
- Postmenopausal and under 65: get one earlier if a clinical risk check puts you at higher fracture risk. Doctors use short calculators like FRAX, OST, or ORAI. Risk factors include low body weight, a prior fragility fracture (a break from a fall at standing height or less), steroid use, early menopause, and family history.
- Men: the same 2025 update found too little evidence to recommend screening (an "I-statement").
- A personal baseline scan earlier in menopause is a longevity-medicine preference, not standard care.
- Put weight-bearing and resistance exercise first.
- Hit your calcium, vitamin D, and protein targets.
- Go easy on alcohol and skip smoking.
- If your bone density is low, ask your doctor about medication options like bisphosphonates.
What makes women's heart risk unique?
Heart disease is the number one killer of women worldwide. Not breast cancer, which is what most people assume. And yet women's heart disease gets missed, undertreated, and understudied more than men's.
What estrogen is doing for your heart: Before menopause, estrogen keeps your cholesterol balance healthy, your blood vessels flexible, and inflammation low. That is why heart attacks in younger women are rare. After menopause, the risk climbs steeply and the gap with men starts to close. In raw numbers, fewer women than men still die of heart disease into their 60s and 70s, but the rate of new cases takes off.
Women's symptoms look different: A lot of women never get the classic crushing chest pain during a heart attack. Instead it can show up as:
- Shortness of breath
- Nausea or vomiting
- Back or jaw pain
- Crushing fatigue
- Dizziness
Because it does not match the textbook picture, the diagnosis gets missed or delayed. Women are more likely to be sent home from the ER while actually having a heart attack.
Risk factors that are specific to women:
- A history of preeclampsia (dangerously high blood pressure in pregnancy) roughly doubles your later risk of coronary heart disease and stroke [3]. That same 2017 meta-analysis (a study that pools many studies together) found about 4x the rate of heart failure (a heart that pumps too weakly). A newer 2024 meta-analysis puts that number lower, at about 2.5x [4].
- Gestational diabetes (diabetes that shows up during pregnancy) raises overall cardiovascular risk by around 1.5x [18].
- Polycystic ovary syndrome (PCOS)
- Early menopause (before age 40)
- Autoimmune conditions, because they keep inflammation chronically high
- Depression and chronic stress, both of which hit women harder
What to do about it:
- Know your numbers: blood pressure, cholesterol (including Lp(a)), blood sugar, and hsCRP (a blood marker that tracks inflammation).
- Make aerobic exercise a habit. Aim for 150 minutes of moderate or 75 minutes of vigorous exercise a week.
- Catch metabolic syndrome early. Keep an eye on waist size, triglycerides, and fasting blood sugar.
- Do not wave off symptoms. Speak up when something feels off.
- Talk heart risk with your doctor at menopause, not at 65.
Mammography screening: Heart disease is the number one killer, but breast cancer is still the most common cancer in women. Mammography screening every two years is standard across DACH, but the age limits differ. Germany invites women aged 50 to 69 automatically. Since July 2024 the program runs to 75 (previously 69), but women aged 70 to 75 still have to book the appointment themselves. Austria recommends it from 45 to 74, open from 40. Swiss cantonal programs mostly cover 50 to 69, some up to 74. Women with a family history or dense breast tissue should screen earlier and more closely, often with added ultrasound or MRI. A current mammogram is a sensible baseline before your first HRT consultation.
Why are women more affected by Alzheimer's?
Nearly two-thirds of Alzheimer's patients are women. For decades the explanation was simple: women live longer, so more of them reach the age where Alzheimer's strikes. Newer research says biology plays a part too, not just extra years.
Why women get hit harder:
- When estrogen drops at menopause, the brain changes how it fuels itself. Brain scans show women's brains burn less glucose (their main fuel) during the menopause transition. Blood flow and the brain's energy supply partly pick up the slack. Early lab research hints the brain may also lean on ketones (a backup fuel made from fat) for a while.
- There is a gene variant called APOE4, the strongest genetic risk factor for Alzheimer's. It raises risk much more in women than in men between ages 65 and 75. That window opens roughly 15 years after the average menopause at 51.
- Broken sleep during perimenopause and menopause messes with the brain's overnight cleaning system (scientists call it the glymphatic system). That is the crew that flushes out amyloid, the sticky gunk that builds up in Alzheimer's.
- Chronic stress and depression, both more common in women, are linked to a shrinking memory center (the hippocampus) and higher dementia risk.
Sleep is the lever: Menopause and sleep feed each other in a loop. Hot flashes wreck your sleep, and bad sleep makes menopause feel worse. Protecting sleep through the transition is one of the best things you can do for your brain:
- Keep the bedroom cool (16 to 18 degrees Celsius, or 60 to 65 Fahrenheit).
- Go to bed and get up at the same times.
- Cut caffeine after noon.
- If hot flashes are really shredding your sleep, consider HRT.
Friends are brain insurance: Strong social ties are one of the most powerful protections against mental decline we know of. Women tend to keep bigger social networks than men. That may partly explain why they often stay sharp despite the higher Alzheimer's risk. So keeping friendships alive is not just nice to do. It is a longevity move.
More brain-protecting habits:
- Regular aerobic exercise, which raises BDNF (a protein that acts like fertilizer for your brain cells)
- Keep learning, read, try new things
- Eat Mediterranean-style, especially omega-3 fats
- Manage stress
- Treat hearing loss. It is one of the few dementia risk factors you can actually fix
- Sort out sleep problems early, especially during perimenopause
What should women eat for longevity?
For longevity, women should prioritize protein (at least 1.2 g per kg body weight, spread across meals), omega-3 (1 to 2 g EPA/DHA daily), and bone nutrients (1,000 to 1,200 mg calcium plus 1000 to 2000 IU vitamin D after 50), while cutting iron back to 8 mg post-menopause. What your body needs from food shifts a lot across your life. A one-size plan misses the parts that matter most for women.
Iron flips after menopause: Before menopause, women need about 18 mg of iron a day to make up for what they lose with periods. After menopause that drops to 8 mg, the same as men. Too much iron also acts as a pro-oxidant (it can drive the kind of cell damage that ages you), so more is not better. Once you are postmenopausal, skip iron-fortified supplements unless a blood test confirms you are actually low.
Iron status, how to measure it right: Hemoglobin alone is not enough. Have ferritin (your iron stores), transferrin saturation, and CRP measured together. Low ferritin under 50 ng/mL causes fatigue, hair loss, and poor exercise tolerance long before hemoglobin looks off. You need CRP alongside it because ferritin is an acute-phase protein and can read falsely high when there is inflammation. In late perimenopause, heavy bleeding can empty your stores. After menopause the picture flips, and the priority becomes avoiding an excess.
Folate: You need it through your fertile years to build DNA and run methylation (tiny chemical tags that switch genes on and off). It still matters later for how your genes behave. Aim for 400 to 800 mcg a day, ideally from food: leafy greens, beans and lentils, fortified grains. For a supplement, either methylfolate (L-5-MTHF) or plain folic acid works. You may have heard that people with an MTHFR gene variant should avoid folic acid. That is not backed by the CDC or the major guidelines. And if you are planning a pregnancy, folic acid has the strongest trial evidence for preventing neural tube defects (serious birth defects of the brain and spine).
Omega-3 fats: The two that matter, DHA and EPA, support your heart, brain, and inflammation control. Women may benefit from 1 to 2 grams of combined EPA and DHA daily, especially after menopause when estrogen's heart protection fades.
Protein, more than you think: Most women eat too little protein, year after year. The research keeps pushing the target higher for aging women:
- Aim for at least 1.2 g per kg of body weight a day (so about 72 g for a 60 kg woman). An expert group on older adults recommends 1.0 to 1.2 g/kg, and more if you are active [16].
- Spread it across meals. Hitting 30+ grams in one sitting kicks off muscle building far better than nibbling protein all day.
- Lean on leucine-rich foods (leucine is the amino acid that flips the muscle-building switch): eggs, dairy, fish, poultry, soy.
Our protein calculator turns your weight and activity into a daily gram target, per meal and in g/kg.
Phytoestrogens: Plant compounds (isoflavones in soy, lignans in flaxseed) that latch weakly onto your estrogen receptors. They may take the edge off mild menopause symptoms and help your bones. Traditional Asian diets high in soy are linked to lower rates of osteoporosis and hot flashes. Genes and a lifetime of eating that way play a role too, so it is not soy alone.
Other nutrients worth tracking:
- Calcium: 1,000 to 1,200 mg a day after 50, food first
- Vitamin D: 1000 to 2000 IU daily. Test your level once a year
- Magnesium: 320 mg a day. Helps sleep, bones, and mood
- Vitamin K2: Often taken alongside calcium and D3, on the theory it steers calcium into bone. The human outcome data are mixed, and Europe's food-safety authority (EFSA) rejected the K2 heart-and-blood-vessel claims in 2012 and 2020. Treat it as optional, not essential
- B12: Your gut absorbs less of it as you age. Worth supplementing after 50
What are the best longevity exercises for women?
For women over 40, strength training matters most: 2 to 4 sessions a week directly counters osteoporosis, muscle loss, a slowing metabolism, and falls. Pair it with Zone 2 cardio (150 to 180 minutes weekly) and pelvic floor work. If one habit pushes back on almost every problem of female aging at once, it is exercise. Bone loss, muscle decline, heart risk, brain health, mood, metabolism. All of it responds. And yet exercise guidelines were built around male bodies for decades.
Strength training comes first: For women over 40, lifting weights is arguably more important than cardio. It goes straight at the biggest threats: osteoporosis, muscle loss, a slowing metabolism, and falls.
- Aim for 2 to 4 sessions a week.
- Use compound lifts that work many muscles at once: squats, deadlifts, rows, presses.
- Add a little weight over time. That slow progression is what makes muscle and bone adapt.
- Do not fear heavy weights. Women have about 10% of men's testosterone, so you will not accidentally bulk up.
Zone 2 cardio for your metabolism: This is easy aerobic work at a pace where you can still hold a conversation (a brisk walk, cycling, easy swimming). It builds up your mitochondria (the tiny power plants in your cells) and trains your body to burn fat. It matters more after menopause, when your metabolism tends to slow.
- Aim for 150 to 180 minutes a week.
- Keep it easy enough to talk.
- Great for the heart without pounding your joints.
Pelvic floor training: Your pelvic floor is the sling of muscles that holds up your bladder, uterus, and bowel. When it weakens, you get urinary leaks, which affect up to 50% of older women.
- Kegel exercises strengthen it.
- Breathing well and bracing your core while you lift protects it too.
- A pelvic floor physiotherapist can build you a personal plan.
Your recovery is different: Thanks to hormones, women recover differently than men:
- You may handle training more often, but you still need real rest between heavy sessions.
- Sleep drives recovery. So fix the menopause sleep problems.
- Manage stress. The stress hormone cortisol blocks recovery and parks fat around your belly.
- Timing helps: protein within 1 to 2 hours after a workout supports muscle repair.
A sample week:
- 2 to 3 strength sessions (full body, or upper/lower split)
- 2 to 3 Zone 2 cardio sessions (30 to 45 minutes)
- Daily pelvic floor exercises
- 1 to 2 flexibility and mobility sessions (yoga, stretching)
- At least 1 rest day a week
Where do you start?
Start this week with three moves: begin strength training, add protein to every meal, and fix your sleep schedule. Within a month, book a full blood panel (lipids, hsCRP, vitamin D, thyroid, ferritin, HbA1c) and at your next visit raise HRT, heart risk, and DEXA timing. Here is the roadmap, step by step:
This week:
- Start strength training, even just bodyweight at home.
- Add a serving of protein to every meal.
- Set a consistent sleep schedule.
Within the first month:
- Book a full blood panel: metabolic panel, lipids, hsCRP, vitamin D, thyroid (TSH and free T4), iron and ferritin, and HbA1c (your average blood sugar over the last 3 months).
- Start a daily vitamin D supplement if you are not already.
- Start a 30-minute daily walk (that counts as Zone 2 cardio).
At your next doctor's visit:
- Go through your heart risk, especially if you are near or past menopause.
- Ask about HRT if menopause symptoms are bothering you. You have every right to an informed conversation. Our HRT guide goes deeper.
- Ask when you should get a DEXA bone scan. USPSTF (final recommendation updated 14 January 2025) says routine screening at 65 or older (Grade B), and earlier for postmenopausal women under 65 at higher fracture risk based on a clinical check (FRAX, OST, or ORAI; risk factors include low weight, a prior fragility fracture, steroid use, early menopause, family history). An earlier baseline at menopause is a longevity-medicine choice, not a standard guideline.
- Bring up any pregnancy complications (preeclampsia, gestational diabetes). They are flags for future heart risk.
- Plan your next mammogram if you are in your screening age range (every two years; Germany 50 to 75, Austria 45 to 74).
Markers to track over time:
- Bone density (DEXA every 2 years after menopause)
- Heart markers: blood pressure, LDL/HDL, triglycerides, Lp(a), hsCRP
- Metabolic health: fasting glucose, HbA1c, insulin
- Hormones: estradiol, FSH, thyroid panel, vitamin D
- Body composition: muscle mass, waist size
When to see a specialist:
- A menopause-trained gynecologist or endocrinologist for hormone care
- A pelvic floor physiotherapist if you deal with leaks
- An endocrinologist if a thyroid problem is suspected
- A cardiologist if you have pregnancy-related risk factors or a family history
How do you find a menopause-literate physician in DACH?
The quality of menopause care swings wildly across German-speaking countries. The right doctor can be the difference between years of having your symptoms brushed off and a plan that actually works. Start with the national societies, then screen for how up-to-date a practice is with a quick phone call.
Germany: The Deutsche Menopause Gesellschaft (DMG) certifies individual doctors as "Menopause-SpezialistIn (MePaS)". There is no public search, so ask the practice directly whether a doctor holds it. The most specialized group are gynecologists with the subspecialty (Schwerpunkt) Gynäkologische Endokrinologie und Reproduktionsmedizin. Big academic centers (Charité Berlin, LMU Munich, UKE Hamburg) often run dedicated menopause clinics.
Austria: The Österreichische Gesellschaft für Gynäkologie und Geburtshilfe (ÖGGG) keeps a list of menopause experts. Vienna has the densest network of menopause-trained gynecologists.
Switzerland: The Schweizerische Gesellschaft für Gynäkologische Endokrinologie, Kontrazeption und Menopause (SGEM, formerly the Schweizerische Menopausegesellschaft) at gynendo.ch publishes guidelines but no public doctor list, so ask whether a gynecologist is an SGEM member. The Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe (SGGG) is the general gynecology society and also lists practitioners. University hospitals in Zurich, Bern, Geneva, and Basel run specialist menopause consultations.
Red flag: A gynecologist who shoots down any HRT discussion on reflex by quoting WHI 2002. The 2017 reanalysis and the North American Menopause Society 2022 position statement (renamed The Menopause Society in 2023) largely rehabilitated HRT for the right patients, especially when it starts inside the timing window (within 10 years of the last period, before age 60). In 2025 the US FDA also moved to drop its broad boxed warnings [10]. A flat "no" tells you the doctor has not updated their thinking in two decades.
Green flags:
- She knows the difference between transdermal and oral estradiol.
- She prescribes micronized progesterone (Utrogest, Famenita) without flinching.
- She is happy to walk you through the timing hypothesis and your personal risk versus benefit.
- She asks about symptoms beyond hot flashes: mood, brain fog, joint pain, how your sleep is structured.
What does DACH HRT actually look like (formulations, costs, prescribing)?
Standard DACH HRT is transdermal estradiol (Gynokadin Gel or Estramon patch) plus oral micronized progesterone (Utrogest 100 mg), the bioidentical combo your insurance covers. In Germany you pay only the normal prescription co-pay. Once you have a menopause-savvy doctor, here is what standard care actually looks like at the pharmacy counter in DACH. Knowing it lets you check whether your prescription matches current best practice. For a deeper look at the active ingredients, regimens, and risks, see our HRT guide.
| Product | Active ingredient | Route | What it is for |
|---|---|---|---|
| Gynokadin Gel | estradiol | skin gel | systemic HRT |
| Estramon | estradiol | skin patch | systemic HRT |
| Utrogest / Famenita | micronized progesterone | capsule | protects the uterus lining |
| Ovestin / Oekolp | estriol | vaginal cream | local dryness and discomfort |
| Estring | estradiol | vaginal ring | local symptoms |
The bioidentical combo your insurance covers (what most patients get): Estradiol through the skin (Gynokadin Gel you rub on, or Estramon patches) plus oral micronized progesterone (Utrogest 100 mg or Famenita). Because the skin route skips the first pass through your liver, it carries lower clot and stroke risk than estradiol pills. Micronized progesterone is body-identical and is easier on breast tissue and sleep than the older synthetic versions. Cost with a Rezept (prescription): in Germany the normal GKV co-pay of €5 to €10 per pack. In Austria you pay the Rezeptgebühr, in Switzerland your deductible (Franchise).
The non-standard compounded stuff: Estradiol or testosterone creams mixed at a Rezeptur-Apotheke, or DHEA and pregnenolone ordered through specialist Internationale Apotheken in Germany. You pay for these yourself (Selbstzahler), and costs swing a lot. Compounded hormones are not somehow better than the bioidenticals your insurance already covers. The data favor the standard products.
How it usually gets prescribed:
- Perimenopause, uterus intact: Estradiol every day + progesterone for 12 to 14 days a month (called sequential). This usually gives you a predictable monthly bleed.
- Post-menopause (12+ months with no period): Continuous combined, meaning estradiol and progesterone both daily. No scheduled bleed.
- After a hysterectomy: Estradiol on its own. No progesterone needed.
Vaginal estrogen, for local symptoms only: Ovestin cream or Oekolp (both estriol), or the slow-release Estring ring (estradiol). Good for vaginal dryness, painful sex, and recurring urinary tract infections. Almost none of it gets into your bloodstream, so it is generally considered safe even for women who cannot take systemic HRT, including many breast cancer survivors (check with your oncologist).
Which blood tests should women get at 40?
Your age-40 screening panel should cover TSH and free T4 (thyroid), ferritin and B12 (iron stores), 25-OH vitamin D, a fasting lipid panel including a one-time Lp(a), HbA1c and fasting glucose, plus AMH if fertility still matters. A lot of perimenopause symptoms (fatigue, brain fog, low mood, weight gain) overlap with thyroid disease, low iron, and early metabolic trouble. A solid baseline panel around age 40 sorts out what is actually hormonal from what you can fix more cheaply. Our perimenopause guide covers the phase itself in more detail.
The core panel to ask your GP (Hausarzt) or gynecologist for:
- TSH + free T4: These check your thyroid, which often acts up in women and mimics perimenopause almost exactly. Get it regardless of symptoms.
- Ferritin and B12: Ferritin shows your iron stores. It tracks energy and focus more closely than hemoglobin alone. Low ferritin (under 50 ng/mL) is common in women who still have periods and causes symptoms long before you would ever look anemic. B12 absorption also drops with age.
- 25-OH vitamin D: Aim for 30 to 50 ng/mL (75 to 125 nmol/L). At DACH latitudes you make essentially no vitamin D from October to April.
- Fasting lipid panel including Lp(a): Your standard cholesterol numbers, plus a one-time Lp(a). Lp(a) is mostly inherited, barely budges over your life, and is a strong stand-alone predictor of heart risk. Measure it once and it informs your risk for life.
- HbA1c and fasting glucose: Early insulin resistance in perimenopause is common and easy to miss.
- AMH (anti-Müllerian hormone) if fertility still matters to you: FSH is unreliable in perimenopause because it swings all over the place across your cycle. AMH gives a steadier read on your egg reserve.
- Blood pressure, waist circumference, resting heart rate: Cheap, easy to repeat, and together more predictive than most lab numbers.
A bone baseline around menopause (a longevity-medicine choice, not standard screening): USPSTF (updated 14 January 2025) recommends a routine DEXA at 65 (Grade B). It recommends one earlier if you are postmenopausal and a clinical risk check (FRAX, OST, or ORAI) puts you at higher fracture risk. Risk factors: low weight, a prior fragility fracture, steroid use, early menopause before 40, family history. Some longevity-minded doctors suggest a personal baseline right at menopause, so you can track your own trend instead of just comparing yourself to the average. That is a preference, not a guideline. Insurance follows the guideline: GKV usually only pays for a DEXA when there is a specific medical reason. Ask your gynecologist which of those risk factors apply to you.
Which symptom means which next step?
Match the symptom to the next step: hot flashes plus bad sleep point to systemic HRT, vaginal dryness alone to topical estrogen, mood and brain fog to a thyroid and iron check first, bone worries to a DEXA scan, and any bleeding after 12 months without a period to a prompt gynecologist visit. When you walk into a gynecology appointment, doctors respond better to a specific cluster of symptoms than to "I don't feel right." Use this as a cheat sheet to frame the conversation and know what to ask for.
Hot flashes + bad sleep: Talk about systemic HRT. The timing window (within 10 years of your last period, before age 60) is when the benefits most clearly beat the risks for the right patients. Estradiol through the skin + micronized progesterone is the standard combo to start.
Vaginal dryness or painful sex, and nothing else: Ask about topical estriol cream (Ovestin) or the Estring ring (estradiol). Almost none of it reaches your bloodstream, so the risk profile is nothing like systemic HRT. Often fine even when systemic HRT is not.
Mood swings, brain fog, broken sleep: Rule out thyroid trouble and low iron first (TSH, free T4, ferritin). They cause the same symptoms and are cheaper to fix. If those come back clean, then talk HRT. Progesterone in particular can smooth out your sleep.
Worried about bones, or fractures run in the family: Ask for a DEXA scan. Then talk through this with your gynecologist or GP: calcium 1,000 to 1,200 mg a day from food where you can, D3 1,000 to 2,000 IU daily, K2 MK-7 100 mcg, and 2 to 3 strength sessions a week. Bone drugs like bisphosphonates are usually offered if your T-score is -2.5 or lower, if you have had a fragility fracture, or if you have osteopenia (mildly low bone density) plus a high calculated fracture risk, for example from FRAX [17]. In Germany the DVO guideline bases the decision on your 3-year fracture risk. So osteopenia alone is not a reason for drugs, but osteopenia plus high risk can be. Strength training helps either way.
Weight gain around menopause: Three approaches have evidence behind them:
- Protein at 1.6 to 2.0 g/kg of body weight a day. That is the range the muscle-preservation studies in older adults used. The 1.2 g/kg figure earlier in this guide is your general floor.
- Strength training 2 to 3 times a week.
- Zone 2 cardio, 150 to 180 minutes a week.
You could also wear a continuous glucose monitor (Libre, Dexcom) for 2 to 4 weeks to see how your own blood sugar reacts to meals. The foods that spike your blood sugar are often not the ones you would guess.
Heavy or unpredictable bleeding, or any bleeding after 12 months with no period: This is not a longevity question. Book a gynecologist soon. Bleeding after menopause needs the lining of the uterus checked.
How do you hit protein and bone targets in a DACH kitchen?
From a DACH kitchen, aim for at least 30 g of protein per meal (Skyr, eggs, chicken, lentils) and 1,000 to 1,200 mg of calcium a day (Quark, cheese, sardines, kale). Add 300 to 400 mg of magnesium (pumpkin seeds, whole-grain bread) and 1,000 to 2,000 IU of vitamin D3 year-round. Here are realistic targets, per meal and per day, straight from a DACH grocery store.
Protein: at least 30 g per meal: That is the amount that reliably switches on muscle building. Where most women fall short is breakfast. Easy DACH combos:
- 150 g Skyr or Magerquark (15 to 17 g protein)
- 3 eggs (18 g)
- 100 g chicken breast (23 g)
- 100 g cooked lentils (9 g, plus fiber)
- 30 g Parmesan or aged Gouda (10 g)
- 100 g Lachs or Hering (salmon or herring, 20 g)
- 200 g tofu (16 g)
Stack two or three of these per meal to clear 30 g without thinking about it. Breakfast example: 150 g Skyr + 2 eggs + 30 g nuts = about 35 g.
Calcium: 1,000 to 1,200 mg a day: Food first. DACH staples cover it well: Quark, Skyr, plain yogurt, Emmentaler, Gouda, Parmesan, sardines with the bones, sesame (Tahini), Grünkohl (kale), broccoli, and fortified plant milks. 200 g Skyr + 40 g Emmentaler + a portion of Grünkohl easily covers a day. Reach for a supplement only if food does not get you there.
Magnesium: 300 to 400 mg a day: Pumpkin seeds, sunflower seeds, Vollkornbrot (whole-grain bread), Haferflocken (oats), dark chocolate (70%+), spinach, almonds. Magnesium helps your sleep, your bone structure, and how your body handles blood sugar. A small handful of pumpkin seeds a day plus a whole-grain-heavy diet usually does it.
Vitamin D3 + K2: 1,000 to 2,000 IU of D3 a day is a sensible year-round dose at DACH latitudes. From October through April, your skin makes basically no vitamin D this far north. Adding 100 mcg of K2 MK-7 is a common longevity-medicine add-on, the idea being it helps steer calcium into bone. The human outcome data are mixed, though. Europe's food-safety authority (EFSA) rejected the K2 heart-and-blood-vessel claims in 2012 and again in 2020 (the MenaQ7 arterial-stiffness opinion) [19, 20]. So treat K2 as optional, not essential. Both are cheap and low-risk.
Do GLP-1s interact with HRT?
Sometimes, and mostly with oral hormones. Tirzepatide (Mounjaro) slows stomach emptying enough to lower how much of the pill you absorb, so its label asks for a backup method. Semaglutide (Ozempic, Wegovy) showed no meaningful effect on the pill in its studies. Estradiol through a patch or gel is unaffected either way. If you are taking or thinking about a GLP-1 drug (Ozempic, Wegovy, Mounjaro) while you are also on hormone therapy or the pill, the route you take your hormones matters.
GLP-1s slow down how fast your stomach empties, a lot, especially in the first few weeks and after each dose increase. That delay can cut how much of an oral medication your body actually absorbs, including the pill and oral estradiol. How much it matters depends on the drug and on you. For the pill, the makers of tirzepatide flat out recommend either switching to a non-pill method or adding a barrier method (like condoms) for 4 weeks after you start and after every dose increase. For semaglutide (Ozempic, Wegovy), the drug studies found no clinically relevant change in pill hormone levels.
What this means in practice:
- Estradiol through the skin is not affected by slow stomach emptying. Gynokadin Gel, Estramon patches, and Estreva work the same on a GLP-1 as off it.
- Oral micronized progesterone (Utrogest, Famenita): Absorption may dip a bit in the early GLP-1 weeks. If you started a GLP-1 recently and your sleep or mood symptoms creep back, talk timing or route with your gynecologist.
- The combined pill: Consider switching to a hormonal IUD or a skin patch, or adding a backup barrier method during the first month and after each dose increase.
Bring up GLP-1 with your gynecologist before you start, not after. The fix is usually simple (move to a skin route or adjust timing), but it should be a planned conversation rather than a problem you stumble into. Our GLP-1 guide has the full prescribing picture in DACH.
Frequently asked questions
Do women age differently than men?
Does HRT help women live longer?
What is the best exercise for women over 40?
How does menopause affect aging?
What supplements should women take for longevity?
Why do women live longer than men?
Does a late menopause mean you live longer?
Can menopause start at 40?
Does HRT make you gain weight?
How much protein do women need in menopause?
Sources
- Manson JE, Aragaki AK, Rossouw JE, et al. (2017). Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: WHI Randomized Trials. JAMAdoi:10.1001/jama.2017.11217
- Greendale GA, Sowers M, Han W, et al. (2012). Bone mineral density loss across the menopausal transition (SWAN). Journal of Bone and Mineral Researchdoi:10.1002/jbmr.534
- Wu P, Haththotuwa R, Kwok CS, et al. (2017). Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomesdoi:10.1161/CIRCOUTCOMES.116.003497
- Inversetti A, Pivato CA, Cristodoro M, et al. (2024). Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis. European Heart Journal - Quality of Care and Clinical Outcomesdoi:10.1093/ehjqcco/qcad065
- NAMS Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopausedoi:10.1097/GME.0000000000002028
- Kraus WE, Bhapkar M, Huffman KM, et al. (2019). 2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial. The Lancet Diabetes & Endocrinologydoi:10.1016/S2213-8587(19)30151-2
- Rossouw JE, Anderson GL, Prentice RL, et al. (2002). Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: WHI. JAMAdoi:10.1001/jama.288.3.321
- Hodis HN, Mack WJ, Henderson VW, et al. (2016). Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol (ELITE). New England Journal of Medicinedoi:10.1056/NEJMoa1505241
- Panay N, Ang SB, Cheshire R, Goldstein SR, Maki P, Nappi RE. (2024). Menopause and MHT in 2024: addressing the key controversies — an International Menopause Society White Paper. Climactericdoi:10.1080/13697137.2024.2394950
- U.S. Food and Drug Administration. (2025). HHS Advances Women's Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
- Shadyab AH, Macera CA, Shaffer RA, et al. (2017). Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative. Menopausedoi:10.1097/GME.0000000000000710
- Muka T, Oliver-Williams C, Kunutsor S, et al. (2016). Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis. JAMA Cardiologydoi:10.1001/jamacardio.2016.2415
- Collaborative Group on Hormonal Factors in Breast Cancer. (2012). Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. The Lancet Oncologydoi:10.1016/S1470-2045(12)70425-4
- Statistisches Bundesamt (Destatis). (2026). Sterbefälle und Lebenserwartung: Lebenserwartung bei Geburt, Sterbetafel 2023/2025
- Norman RJ, Flight IH, Rees MC. (2000). Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviewsdoi:10.1002/14651858.CD001018
- Bauer J, Biolo G, Cederholm T, et al. (2013). Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group. Journal of the American Medical Directors Associationdoi:10.1016/j.jamda.2013.05.021
- LeBoff MS, Greenspan SL, Insogna KL, et al. (2022). The clinician's guide to prevention and treatment of osteoporosis. Osteoporosis Internationaldoi:10.1007/s00198-021-05900-y
- Xie W, Wang Y, Xiao S, et al. (2022). Association of gestational diabetes mellitus with overall and type specific cardiovascular and cerebrovascular diseases: systematic review and meta-analysis. BMJdoi:10.1136/bmj-2022-070244
- EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). (2012). Scientific Opinion on the substantiation of a health claim related to vitamin K2 and contribution to the normal function of the heart and blood vessels (ID 125, further assessment). EFSA Journaldoi:10.2903/j.efsa.2012.2714
- EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). (2020). MenaQ7 and maintenance of the elastic properties of the arteries: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journaldoi:10.2903/j.efsa.2020.5949
Curious about your biological age?
Take our free AI-powered photo test to estimate your visible facial age from facial markers. It's a rough proxy for how your lifestyle is showing up in your skin. True biological age is measured at the cellular level (epigenetic clocks, blood biomarkers) and can't be read from a photo, so treat this as a quick snapshot, not a clinical readout.
Try Free Face AgeExperts in this field
Speakers from the Longevity Austria community on this topic
Related guides
Biological vs chronological age
Why your biological age matters more than your birthday
Longevity supplements
What the science really says about NMN, Vitamin D, Omega-3, and more.
Exercise for longevity
The best types and amounts of exercise for a longer life.
Creatine for women
Strength, brain, and the menopause transition. What the RCTs really show for women, plus honest myth-busting on kidneys and bloating.
Menopause symptoms: The complete hub
Hot flushes, weight, brain fog, joints, sleep and skin. What is really behind the symptoms and what actually helps, honestly framed.
Stop skin aging
Sugar, collagen, sun protection and menopause. What keeps skin visibly younger, based on what the dermatology evidence actually shows.
Created by Maurice Lichtenberg, Founder, Longevity Cities
The information provided here is for educational purposes only. Longevity Austria does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.
